Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Ernesto Paoletti"'
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Hyperkalemia (HK) is frequently present in chronic kidney disease (CKD). Risk factors for HK among CKD patients include comorbidities and renin–angiotensin–aldosterone system inhibitor (RAASi) treatment. Current standard of ca
Externí odkaz:
https://doaj.org/article/8d4d1d3f8b934fc3adf2b91b191b2778
Autor:
Maria Rendina, Ernesto Paoletti, Nunzia Labarile, Antonella Marra, Andrea Iannone, Antonino Castellaneta, Elisabetta Bussalino, Maura Ravera, Antonio Schena, Nicola M. Castellaneta, Michele Barone, Simona Simone, Loreto Gesualdo, Alfredo Di Leo
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Background/aim: Direct-acting antivirals (DAAs) have improved the treatment of HCV-positive kidney transplant recipients (KTRs). However, their medium-term follow-up effects on graft function are conflicting. This study aimed to analyze how the inter
Externí odkaz:
https://doaj.org/article/c633282e248c46dcaf6784bac45b80bd
Autor:
Valeria Cademartori, Fabio Massarino, Emanuele L. Parodi, Ernesto Paoletti, Rodolfo Russo, Antonella Sofia, Iris Fontana, Francesca Viazzi, Pasquale Esposito, Giacomo Garibotto
Publikováno v:
Transplantology, Vol 2, Iss 1, Pp 49-56 (2021)
The use of tacrolimus (Tac) may be involved in the development of new-onset diabetes after transplantation (NODAT) in a dose-related manner. This study aimed to evaluate the effects of a standard twice-daily formulation of Tac (TacBID) vs. the once-d
Externí odkaz:
https://doaj.org/article/ff0037c2ab4b40d4bf146986bf490825
Publikováno v:
Case Reports in Transplantation, Vol 2021 (2021)
Introduction. Hepatitis C virus (HCV) infection continues to represent a poor prognostic factor in kidney transplant (KTx) patients. New direct-acting antiviral agents (DAA) have dramatically changed the therapy management for HCV, showing promising
Externí odkaz:
https://doaj.org/article/293ffecd9c154a218be8d613a235118c
Autor:
Silvio Borrelli, Luca De Nicola, Carlo Garofalo, Ernesto Paoletti, Sergio Lucà, Paolo Chiodini, Stefano Lucà, Nicola Peruzzu, Antonella Netti, Eugenio Lembo, Giovanna Stanzione, Giuseppe Conte, Roberto Minutolo
Publikováno v:
Journal of Hypertension. 40:723-731
Background: Left ventricular (LV) diastolic dysfunction is common in non-dialysis chronic kidney disease (ND-CKD) patients; however, the prevalence estimated according to the new diagnostic criteria as well as the prognostic role of diastolic dysfunc
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation SocietyREFERENCES. 24(6)
Autor:
Diego Bellino, Maura Ravera, Elisabetta Bussalino, Laura Panaro, Luigina Marsano, Ernesto Paoletti
Publikováno v:
Internal and Emergency Medicine. 16:1787-1792
Although hyperkalemia (HK) is often associated with adverse clinical outcomes in renal patients, few studies are available in the setting of kidney transplantation. Therefore, we evaluated prevalence and clinical correlates of HK in stable kidney tra
Autor:
Iris Fontana, Antonella Sofia, Ernesto Paoletti, Francesca Viazzi, Fabio Massarino, Emanuele Luigi Parodi, Rodolfo Russo, Valeria Cademartori, Pasquale Esposito, Giacomo Garibotto
Publikováno v:
Transplantology, Vol 2, Iss 5, Pp 49-56 (2021)
Transplantology
Volume 2
Issue 1
Pages 5-56
Transplantology
Volume 2
Issue 1
Pages 5-56
The use of tacrolimus (Tac) may be involved in the development of new-onset diabetes after transplantation (NODAT) in a dose-related manner. This study aimed to evaluate the effects of a standard twice-daily formulation of Tac (TacBID) vs. the once-d
Autor:
Emanuele Luigi Parodi, Francesca Cappadona, Daniela Picciotto, E. La Porta, Fabio Massarino, Francesca Viazzi, Abitha Murugavel, Giacomo Garibotto, Luigina Marsano, Diego Bellino, Ernesto Paoletti, Iris Fontana, Rodolfo Russo, Pasquale Esposito, Antonella Sofia
Publikováno v:
Transplantation Proceedings. 52:3112-3117
Tacrolimus is a cornerstone in the immunosuppressive therapy of kidney transplantation. The once-daily formulation of tacrolimus has been shown to improve adherence of patients without affecting short-term efficacy. However, long-term proof of once-d
Autor:
Silvio Borrelli, Luca De Nicola, Carlo Garofalo, Eugenio Lembo, Antonella Netti, Sergio Lucà, Stefano Lucà, Paolo Chiodini, Ernesto Paoletti, Giovanna Stanzione, Giuseppe Conte, Roberto Minutolo
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Left ventricular (LV) diastolic dysfunction is common in nondialysis chronic kidney disease (ND-CKD) patients; however, the prevalence estimated according to the new diagnostic criteria as well as the prognostic role of diastolic